Stock analysts at StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a note issued to investors on Thursday. The brokerage set a “buy” rating on the stock.
Mannatech Price Performance
MTEX stock opened at $7.68 on Thursday. The company has a quick ratio of 0.51, a current ratio of 1.07 and a debt-to-equity ratio of 0.09. The business has a 50 day moving average of $8.48 and a 200-day moving average of $8.70. Mannatech has a 12-month low of $7.50 and a 12-month high of $15.10.
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its quarterly earnings data on Thursday, March 28th. The company reported ($0.94) earnings per share (EPS) for the quarter. The business had revenue of $32.69 million during the quarter. Mannatech had a negative net margin of 1.70% and a negative return on equity of 19.19%.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
See Also
- Five stocks we like better than Mannatech
- Trading Stocks: RSI and Why it’s Useful
- MarketBeat Week in Review – 4/29 – 5/3
- The “How” and “Why” of Investing in 5G Stocks
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What is the Australian Securities Exchange (ASX)
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
